These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22325829)

  • 1. Botulinum neurotoxin treatment in children with cerebral palsy: a population-based study in Norway.
    Elkamil AI; Andersen GL; Skranes J; Lamvik T; Vik T
    Eur J Paediatr Neurol; 2012 Sep; 16(5):522-7. PubMed ID: 22325829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.
    Pin TW; Elmasry J; Lewis J
    Dev Med Child Neurol; 2013 Apr; 55(4):304-13. PubMed ID: 23095013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between gross motor capacity and daily-life mobility in children with cerebral palsy.
    Smits DW; Gorter JW; Ketelaar M; Van Schie PE; Dallmeijer AJ; Lindeman E; Jongmans MJ
    Dev Med Child Neurol; 2010 Mar; 52(3):e60-6. PubMed ID: 20002126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross and fine motor function and accompanying impairments in cerebral palsy.
    Himmelmann K; Beckung E; Hagberg G; Uvebrant P
    Dev Med Child Neurol; 2006 Jun; 48(6):417-23. PubMed ID: 16700930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of cerebral palsy subtype and functional motor impairment: a population-based study.
    Shevell MI; Dagenais L; Hall N;
    Dev Med Child Neurol; 2009 Nov; 51(11):872-7. PubMed ID: 19416339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractures in children with cerebral palsy: a total population study.
    Uddenfeldt Wort U; Nordmark E; Wagner P; Düppe H; Westbom L
    Dev Med Child Neurol; 2013 Sep; 55(9):821-6. PubMed ID: 23750743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral palsy in Norway: prevalence, subtypes and severity.
    Andersen GL; Irgens LM; Haagaas I; Skranes JS; Meberg AE; Vik T
    Eur J Paediatr Neurol; 2008 Jan; 12(1):4-13. PubMed ID: 17574886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
    Yap R; Majnemer A; Benaroch T; Cantin MA
    Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years.
    Ramstad K; Jahnsen R; Skjeldal OH; Diseth TH
    Dev Med Child Neurol; 2011 Nov; 53(11):1013-8. PubMed ID: 22014321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
    Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of gross motor function in extremely low birth weight children with cerebral palsy at 18 months of age.
    Vohr BR; Msall ME; Wilson D; Wright LL; McDonald S; Poole WK
    Pediatrics; 2005 Jul; 116(1):123-9. PubMed ID: 15995042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study.
    Bandholm T; Jensen BR; Nielsen LM; Rasmussen H; Bencke J; Curtis D; Pedersen SA; Sonne-Holm S
    NeuroRehabilitation; 2012; 30(4):277-86. PubMed ID: 22672941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
    Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
    Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
    Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
    Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.